In addition, ASNS inhibition promotes aspartate accumulation, activates p53, and suppresses prostate cancer growth by regulating metabolic pathways, DNA repair, cell cycle progression, and apoptosis (22). This evidence concerns the gene ASNS and prostate carcinoma.